Reinscheid RK - Search Results

1

Pharmacological profile of the neuropeptide S receptor: Dynamic mass redistribution studies.

Ruzza C, Ferrari F, Guerrini R, Marzola E, Preti D, Reinscheid RK, Calo G. Ruzza C, et al. Among authors: reinscheid rk. Pharmacol Res Perspect. 2018 Dec 3;6(6):e00445. doi: 10.1002/prp2.445. eCollection 2018 Dec. Pharmacol Res Perspect. 2018. PMID: 30534379 Free PMC article.

2

In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1.

Camarda V, Ruzza C, Rizzi A, Trapella C, Guerrini R, Reinscheid RK, Calo G. Camarda V, et al. Among authors: reinscheid rk. Peptides. 2013 Oct;48:27-35. doi: 10.1016/j.peptides.2013.07.018. Epub 2013 Jul 30. Peptides. 2013. PMID: 23911665

3

In vitro and in vivo pharmacological characterization of the neuropeptide s receptor antagonist [D-Cys(tBu)5]neuropeptide S.

Camarda V, Rizzi A, Ruzza C, Zucchini S, Marzola G, Marzola E, Guerrini R, Salvadori S, Reinscheid RK, Regoli D, Calò G. Camarda V, et al. Among authors: reinscheid rk. J Pharmacol Exp Ther. 2009 Feb;328(2):549-55. doi: 10.1124/jpet.108.143867. Epub 2008 Oct 29. J Pharmacol Exp Ther. 2009. PMID: 18971372 Free PMC article.

4

Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists.

Guerrini R, Camarda V, Trapella C, Caló G, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S. Guerrini R, et al. Among authors: reinscheid rk. J Med Chem. 2009 Jul 9;52(13):4068-71. doi: 10.1021/jm900604g. J Med Chem. 2009. PMID: 19473027 Free PMC article.

5

Further studies on the pharmacological profile of the neuropeptide S receptor antagonist SHA 68.

Ruzza C, Rizzi A, Trapella C, Pela' M, Camarda V, Ruggieri V, Filaferro M, Cifani C, Reinscheid RK, Vitale G, Ciccocioppo R, Salvadori S, Guerrini R, Calo' G. Ruzza C, et al. Among authors: reinscheid rk. Peptides. 2010 May;31(5):915-25. doi: 10.1016/j.peptides.2010.02.012. Epub 2010 Feb 19. Peptides. 2010. PMID: 20172007

6

In vitro and in vivo pharmacological characterization of a neuropeptide S tetrabranched derivative.

Ruzza C, Rizzi A, Malfacini D, Pulga A, Pacifico S, Salvadori S, Trapella C, Reinscheid RK, Calo G, Guerrini R. Ruzza C, et al. Among authors: reinscheid rk. Pharmacol Res Perspect. 2015 Feb;3(1):e00108. doi: 10.1002/prp2.108. Epub 2015 Jan 5. Pharmacol Res Perspect. 2015. PMID: 25692025 Free PMC article.

7

Structure-Activity Relationship Studies on Oxazolo[3,4-a]pyrazine Derivatives Leading to the Discovery of a Novel Neuropeptide S Receptor Antagonist with Potent In Vivo Activity.

Albanese V, Ruzza C, Marzola E, Bernardi T, Fabbri M, Fantinati A, Trapella C, Reinscheid RK, Ferrari F, Sturaro C, Calò G, Amendola G, Cosconati S, Pacifico S, Guerrini R, Preti D. Albanese V, et al. Among authors: reinscheid rk. J Med Chem. 2021 Apr 8;64(7):4089-4108. doi: 10.1021/acs.jmedchem.0c02223. Epub 2021 Mar 18. J Med Chem. 2021. PMID: 33733768 Free PMC article.

8

Synthesis and biological activity of human neuropeptide S analogues modified in position 5: identification of potent and pure neuropeptide S receptor antagonists.

Guerrini R, Camarda V, Trapella C, Calò G, Rizzi A, Ruzza C, Fiorini S, Marzola E, Reinscheid RK, Regoli D, Salvadori S. Guerrini R, et al. Among authors: reinscheid rk. J Med Chem. 2009 Jan 22;52(2):524-9. doi: 10.1021/jm8012294. J Med Chem. 2009. PMID: 19113861 Free PMC article.

9

Synthesis and separation of the enantiomers of the neuropeptide S receptor antagonist (9R/S)-3-oxo-1,1-diphenyl-tetrahydro-oxazolo[3,4-a]pyrazine-7-carboxylic acid 4-fluoro-benzylamide (SHA 68).

Trapella C, Pela M, Del Zoppo L, Calo G, Camarda V, Ruzza C, Cavazzini A, Costa V, Bertolasi V, Reinscheid RK, Salvadori S, Guerrini R. Trapella C, et al. Among authors: reinscheid rk. J Med Chem. 2011 Apr 28;54(8):2738-44. doi: 10.1021/jm200138r. Epub 2011 Apr 5. J Med Chem. 2011. PMID: 21466221 Free PMC article.

10

Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Reinscheid RK, Ruzza C. Reinscheid RK, et al. Pharmaceuticals (Basel). 2021 Apr 23;14(5):401. doi: 10.3390/ph14050401. Pharmaceuticals (Basel). 2021. PMID: 33922620 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

96 results

Search Page